Heart Failure Clinical Trials and Women
| Study |
Number of Women |
% Women/Total Patients |
| MERIT-HF |
898 |
23 |
| SOLVD Treatment |
2568 |
20 |
| SOLVD Prevention |
548 |
13 |
| RALES |
446 |
27 |
| EPHESUS |
1918 |
29 |
| DIG |
1519 |
22 |
| CIBIS II |
515 |
19 |
| COPERNICUS |
469 |
20 |
| CHARM - Overall |
2400 |
32 |
| CHARM - Preserved |
1212 |
40 |
| ELITE - II |
966 |
31 |
| Val-HEFT |
1033 |
20 |
| COMPANION |
493 |
32 |
| MIRACLE |
145 |
32 |
| MUSTIC |
47 |
26 |
| A-HEFT |
421 |
40 |
| V-HEFT |
0 |
0 |
| CARE-HF |
216 |
27 |
Dr. Eileen Hsich, specialist in Women & Heart Failure
This information is provided by Cleveland Clinic and is not intended to replace
the medical advice of your doctor or health care provider.
Please consult your health care provider for advice about a specific medical condition.
© Copyright 2013 Cleveland Clinic. All rights reserved.